Myocardial Perfusion Imaging: Clinical Trials

12 trials for Myocardial Perfusion Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 active not recruiting, 1 terminated, 1 unknown. 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 42Completed 2

Follow Myocardial Perfusion Imaging: new trials by email Literature Review of Myocardial Perfusion Imaging trials Research Report on Myocardial Perfusion Imaging

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis
XTR004 - Myocardial Perfusion Imaging, Diagnostic Certainty
Phase 2TerminatedSinotau Pharmaceutical Group172024-12-192026-01-12
The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography
computed tomography perfusion imaging - Coronary Occlusion, Myocardial Ischemia
CompletedNational Institute of Cardiology, Warsaw, Poland272020-02-012024-02-16
Dotarem Evaluation for Myocardial Perfusion CMR
Gadavist 15Ml Solution for Injection - Myocardial Perfusion Imaging, Magnetic Resonance Imaging
CompletedMedical University of South Carolina902019-07-032024-11-12
Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
No study intervention - Coronary Disease, Percutaneous Coronary Intervention
Active not recruitingYale University5002019-04-192026-09-04
Real-Time Myocardial Perfusion Echocardiography in the ICU
Definity - Myocardial Perfusion Imaging
Phase 4CompletedMayo Clinic242017-09-282020-09-09
Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging
myocardial perfusion imaging - Hypertrophic Cardiomyopathy, Myocardial Perfusion Imaging
UnknownFar Eastern Memorial Hospital1002017-05-082017-05-16
Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT
collect examination time, functional and clinical tolerability - Myocardial Perfusion Imaging
CompletedHospices Civils de Lyon3002017-05-032018-04-13
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Myocardial Perfusion Imaging, Computed Tomography
CompletedNational Institute of Cardiology, Warsaw, Poland602016-11-012019-09-17
Meta-Analysis of Stress Myocardial Perfusion Imaging
Coronary Disease, Echocardiography
CompletedAmerican British Cowdray Medical Center230512015-08-032017-06-08
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Ranolazine, Placebo to match ranolazine, SPECT MPI - Myocardial Perfusion Imaging, Myocardial Ischemia
Phase 4CompletedGilead Sciences812010-09-012014-09-03
Myocardial Perfusion Imaging in Liver Transplantation Candidates
Myocardial perfusion imaging - Myocardial Perfusion Imaging, Liver Failure
CompletedUniversity Hospital Birmingham NHS Foundation Trust4032007-09-012019-06-19
Myocardial Perfusion MRI
Gadobutrol (Gadavist,Gadovist, BAY86-4875) - Myocardial Perfusion Imaging, Magnetic Resonance Imaging
Phase 2CompletedBayer2322004-03-012014-05-22

Narrower conditions

Coronary Disease (2)  ·  Myocardial Ischemia (2)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Coronary Artery Disease (1)  ·  Coronary Occlusion (1)  ·  Liver Failure (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Vascular Diseases (5)  ·  Myocardial Ischemia (3)  ·  Coronary Disease (2)  ·  Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiomyopathies (1)  ·  Digestive System Diseases (1)  ·  Heart Valve Diseases (1)  ·  Hepatic Insufficiency (1)  ·  Liver Diseases (1)

Interventions

gadobutrol (2)  ·  Exercise (1)  ·  Functional Status (1)  ·  Injections (1)  ·  Myocardial Perfusion Imaging (1)  ·  Ranolazine (1)  ·  Solutions (1)  ·  perflutren (1)

Sponsors

National Institute of Cardiology, Warsaw, Poland (2)  ·  American British Cowdray Medical Center (1)  ·  Bayer (1)  ·  Far Eastern Memorial Hospital (1)  ·  Gilead Sciences (1)  ·  Hospices Civils de Lyon (1)  ·  Mayo Clinic (1)  ·  Medical University of South Carolina (1)  ·  Sinotau Pharmaceutical Group (1)  ·  University Hospital Birmingham NHS Foundation Trust (1)  ·  Yale University (1)

Countries

United States (4)  ·  Poland (3)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)  ·  Singapore (1)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Cezary Kepka, MD, PhD (1)  ·  Elissa Altin, MD (1)  ·  Joseph U. Schoepf, MD (1)  ·  Lilia M Sierra-Galan, MD, MCvT (1)  ·  Patricia A. Pellikka (1)  ·  Patrick Yue, MD (1)  ·  Richard P Steeds, MD (1)  ·  Yen-Wen Wu, MD, PhD (1)

Results publications

PMID 32394403, PMID 37400307

NIH funding

2005 (1)